Hamilton Wealth’s Novartis NVS Stock Holding History

Hamilton Wealth’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,830	Closed	-$280K	–	136
2026 Q1	$280K	Buy	+1,830	New	+$281K	0.05%	91

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hamilton Wealth's NVS Position: Q2 2026 in Review

Hamilton Wealth sold out of Novartis (NVS) in Q2 2026, closing a stake of 1,830 shares — an estimated $280K sold.

Hamilton Wealth first reported a position in NVS in Q1 2026 and held it in 1 quarter. The position peaked at $280K in Q1 2026. 1,624 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Hamilton Wealth reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
Hamilton Wealth sold 1,830 Novartis shares in Q2 2026, an estimated $280K.
Hamilton Wealth first reported a position in Novartis in Q1 2026 and held it in 1 quarter.
Hamilton Wealth's Novartis position peaked at $280K in Q1 2026.
1,624 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Hamilton Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.